The historical rank and industry rank for Telescope Innovations's Days Payable or its related term are showing as below:
During the past 7 years, Telescope Innovations's highest Days Payable was 40089.17. The lowest was 132.85. And the median was 4813.44.
TELIF's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.36 * Ranked among companies with meaningful Days Payable only.
Telescope Innovations's Days Payable
stayed the same
from May. 2025 (0.00) to May. 2026 (0.00).
stayed the same
Telescope Innovations Days Payable Related Terms
Telescope Innovations Days Payable Historical Data
* Premium members only.
The historical data trend for Telescope Innovations's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TELIF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Telescope Innovations's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telescope Innovations Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Telescope Innovations's Days Payable distribution charts can be found below:
* The bar in red indicates where Telescope Innovations's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Telescope Innovations's Days Payable for the fiscal year that ended in Aug. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telescope Innovations (TELIF) has a Days Payable of 0.00 as of May. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Telescope Innovations and its competitors. Over the past decade, Telescope Innovations' Days Payable has ranged from 132.85 to 40,089.17. According to the industry distribution chart, Telescope Innovations ranks #999999 out of 705 companies in the Biotechnology industry.
Is Telescope Innovations' Days Payable too high?
Telescope Innovations' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 132.85 to a high of 40,089.17. Based on the distribution chart, Telescope Innovations ranks #999999 out of 705 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Telescope Innovations has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Telescope Innovations' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Telescope Innovations ranks #999999 out of 705 companies for Days Payable. This places Telescope Innovations in the lower half of its industry. The industry median Days Payable is 113.36. Historically, Telescope Innovations' own Days Payable has ranged from 132.85 to 40,089.17 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Telescope Innovations and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telescope Innovations's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telescope Innovations stock overvalued right now?
Based on GuruFocus' analysis, Telescope Innovations (TELIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.39, compared to a current price of $0.54 — trading 37.2% above its estimated fair value. The current Days Payable is 0.00. Telescope Innovations' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Telescope Innovations (TELIF), the current Days Payable is 0.00 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Telescope Innovations (TELIF) Overvalued in 2026?
Based on GuruFocus' analysis, Telescope Innovations stock appears to be overvalued.
The current stock price of $0.54 is trading 37.2% above its estimated GF Value™ of $0.39.
GuruFocus considers Telescope Innovations to be Significantly Overvalued.
Key valuation signals for TELIF:
Days Payable: 0.00
GF Value™: $0.39 vs. price of $0.54 (37.2% above fair value)
No single metric tells the full story. See the TELIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Telescope Innovations Corp is a technology company focused on development as a Contract Research Organization (CRO) to develop intellectual property, provide contract research, and build automation products, and operates as a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. Its flagship product is the DirectInject-LC system. The Company operates in a single operating segment and generates revenue from three streams: contract research services, grant income, and the sale of automation products, with the majority of revenue derived from automation product sales from customer contracts. It operates in Canada, the United States, Europe, and Asia, with the majority of revenue coming from the United States.
33GF Score
Get the complete analysis for TELIF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TELIF has been successfully added to your 
